Equities Research Analysts’ price target changes for Wednesday, August 12th:
Agilent Technologies (NYSE:A) had its price target raised by Morgan Stanley from $160.00 to $175.00. They currently have an overweight rating on the stock.
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target increased by Needham & Company LLC from $38.00 to $41.00. Needham & Company LLC currently has a buy rating on the stock.
Admiral Group (LON:ADM) had its target price boosted by Royal Bank Of Canada from GBX 3,450 to GBX 3,950. They currently have a sector perform rating on the stock.
Affirm (NASDAQ:AFRM) had its target price raised by BMO Capital Markets from $78.00 to $86.00. The firm currently has an outperform rating on the stock.
American International Group (NYSE:AIG) had its price target reduced by Morgan Stanley from $82.00 to $81.00. Morgan Stanley currently has an equal weight rating on the stock.
American Integrity Insurance Group (NYSE:AII) had its target price raised by Citizens Jmp from $25.00 to $26.00. Citizens Jmp currently has a market outperform rating on the stock.
Ambiq Micro (NYSE:AMBQ) had its target price raised by Needham & Company LLC from $70.00 to $85.00. They currently have a buy rating on the stock.
American Homes 4 Rent (NYSE:AMH) had its price target reduced by Morgan Stanley from $38.50 to $38.00. They currently have an overweight rating on the stock.
Amentum (NYSE:AMTM) had its target price lowered by Royal Bank Of Canada from $28.00 to $26.00. They currently have a sector perform rating on the stock.
Amentum (NYSE:AMTM) had its target price trimmed by BTIG Research from $35.00 to $30.00. BTIG Research currently has a buy rating on the stock.
APA (NASDAQ:APA) had its target price increased by Benchmark Co. from $40.00 to $46.00. They currently have a buy rating on the stock.
Anadarko Petroleum (NASDAQ:APC) had its price target reduced by UBS Group AG from $22.00 to $21.00. They currently have a buy rating on the stock.
AppLovin (NASDAQ:APP) had its price target cut by BTIG Research from $574.00 to $408.00. They currently have a buy rating on the stock.
Antero Resources (NYSE:AR) had its target price boosted by Benchmark Co. from $44.00 to $47.00. They currently have a buy rating on the stock.
Aramark (NYSE:ARMK) had its target price raised by Robert W. Baird from $63.00 to $69.00. They currently have an outperform rating on the stock.
American Express (NYSE:AXP) had its price target raised by Piper Sandler from $396.00 to $405.00. They currently have an overweight rating on the stock.
Barrick Mining (NYSE:B) (TSE:ABX) had its price target lowered by Scotiabank from $57.00 to $55.00. The firm currently has a sector outperform rating on the stock.
BridgeBio Pharma (NASDAQ:BBIO) had its target price raised by Canaccord Genuity Group Inc. from $104.00 to $106.00. The firm currently has a buy rating on the stock.
BridgeBio Pharma (NASDAQ:BBIO) had its price target increased by JPMorgan Chase & Co. from $100.00 to $111.00. The firm currently has an overweight rating on the stock.
BridgeBio Pharma (NASDAQ:BBIO) had its price target raised by Truist Financial Corporation from $102.00 to $107.00. They currently have a buy rating on the stock.
Tritax Big Box REIT (LON:BBOX) had its target price raised by JPMorgan Chase & Co. from GBX 180 to GBX 190. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Bicara Therapeutics (NASDAQ:BCAX) had its target price boosted by BTIG Research from $28.00 to $39.00. BTIG Research currently has a buy rating on the stock.
Bicara Therapeutics (NASDAQ:BCAX) had its target price raised by Wells Fargo & Company from $16.00 to $23.00. The firm currently has an equal weight rating on the stock.
Bain Capital Specialty Finance (NYSE:BCSF) had its target price trimmed by Wells Fargo & Company from $13.00 to $12.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Lion Finance Group (LON:BGEO) had its price target increased by JPMorgan Chase & Co. from £139 to £141. The firm currently has an overweight rating on the stock.
Bakkt (NYSE:BKKT) had its price target cut by Benchmark Co. from $19.00 to $12.00. They currently have a buy rating on the stock.
Belite Bio (NASDAQ:BLTE) had its target price increased by HC Wainwright from $200.00 to $214.00. They currently have a buy rating on the stock.
Bumble (NASDAQ:BMBL) had its price target reduced by UBS Group AG from $4.50 to $3.00. UBS Group AG currently has a neutral rating on the stock.
Burberry Group (LON:BRBY) had its price target lowered by Citigroup Inc. from GBX 1,560 to GBX 1,510. The firm currently has a buy rating on the stock.
Brainsway (NASDAQ:BWAY) had its target price boosted by BTIG Research from $18.00 to $20.00. They currently have a buy rating on the stock.
Bellway (LON:BWY) had its target price boosted by Citigroup Inc. from GBX 2,300 to GBX 2,500. They currently have a buy rating on the stock.
Bellway (LON:BWY) had its price target lowered by Jefferies Financial Group Inc. from GBX 2,394 to GBX 2,380. Jefferies Financial Group Inc. currently has a buy rating on the stock.
Cardinal Health (NYSE:CAH) had its target price raised by Robert W. Baird from $251.00 to $274.00. The firm currently has an outperform rating on the stock.
Cardinal Health (NYSE:CAH) had its price target boosted by Wells Fargo & Company from $245.00 to $277.00. They currently have an overweight rating on the stock.
CAVA Group (NYSE:CAVA) had its price target increased by Royal Bank Of Canada from $90.00 to $95.00. Royal Bank Of Canada currently has an outperform rating on the stock.
CAVA Group (NYSE:CAVA) had its target price reduced by KeyCorp from $110.00 to $95.00. KeyCorp currently has an overweight rating on the stock.
Crescent Capital BDC (NASDAQ:CCAP) had its target price reduced by Wells Fargo & Company from $12.00 to $11.00. Wells Fargo & Company currently has an equal weight rating on the stock.
CI&T (NYSE:CINT) had its price target cut by UBS Group AG from $7.20 to $6.20. The firm currently has a buy rating on the stock.
CI&T (NYSE:CINT) had its target price lowered by JPMorgan Chase & Co. from $6.00 to $5.00. The firm currently has an overweight rating on the stock.
CI&T (NYSE:CINT) had its target price lowered by TD Cowen from $6.00 to $5.00. The firm currently has a buy rating on the stock.
CLS (LON:CLI) had its target price reduced by Berenberg Bank from GBX 58 to GBX 51. They currently have a buy rating on the stock.
Calumet (NASDAQ:CLMT) had its target price increased by TD Cowen from $34.00 to $40.00. TD Cowen currently has a hold rating on the stock.
Corebridge Financial (NYSE:CRBG) had its target price raised by Piper Sandler from $36.00 to $38.00. The firm currently has an overweight rating on the stock.
California Resources (NYSE:CRC) had its price target trimmed by UBS Group AG from $70.00 to $67.00. UBS Group AG currently has a buy rating on the stock.
Salesforce (NYSE:CRM) had its price target boosted by UBS Group AG from $185.00 to $210.00. The firm currently has a neutral rating on the stock.
Salesforce (NYSE:CRM) had its price target increased by Wells Fargo & Company from $200.00 to $205.00. They currently have an equal weight rating on the stock.
CoreWeave (NASDAQ:CRWV) had its target price boosted by Robert W. Baird from $100.00 to $130.00. They currently have an outperform rating on the stock.
CoreWeave (NASDAQ:CRWV) had its price target increased by Cantor Fitzgerald from $167.00 to $176.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Claritev (NYSE:CTEV) had its price target boosted by Wells Fargo & Company from $22.00 to $30.00. Wells Fargo & Company currently has an equal weight rating on the stock.
CVS Health (NYSE:CVS) had its price target boosted by JPMorgan Chase & Co. from $111.00 to $118.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
DoubleDown Interactive (NASDAQ:DDI) had its price target raised by B. Riley Financial, Inc. from $22.00 to $24.00. The firm currently has a buy rating on the stock.
Diversified Energy (NYSE:DEC) had its price target increased by Truist Financial Corporation from $17.00 to $20.00. Truist Financial Corporation currently has a buy rating on the stock.
Domino’s Pizza Group (LON:DOM) had its target price raised by JPMorgan Chase & Co. from GBX 145 to GBX 167. They currently have an underweight rating on the stock.
DPC (NYSE:DPC) had its price target boosted by Royal Bank Of Canada from $53.00 to $62.00. They currently have an outperform rating on the stock.
DPC (NYSE:DPC) had its target price increased by Morgan Stanley from $47.00 to $59.00. They currently have an equal weight rating on the stock.
DarioHealth (NASDAQ:DRIO) had its target price trimmed by TD Cowen from $11.00 to $8.00. They currently have a hold rating on the stock.
Drax Group (LON:DRX) had its target price trimmed by Jefferies Financial Group Inc. from GBX 920 to GBX 870. They currently have a buy rating on the stock.
Excelerate Energy (NYSE:EE) had its price target raised by Wells Fargo & Company from $37.00 to $38.00. The firm currently has an equal weight rating on the stock.
Elemental Royalty (NASDAQ:ELE) had its price target raised by HC Wainwright from $32.50 to $33.00. HC Wainwright currently has a buy rating on the stock.
Elementis (LON:ELM) had its target price raised by JPMorgan Chase & Co. from GBX 186 to GBX 190. The firm currently has a neutral rating on the stock.
Erasca (NASDAQ:ERAS) had its target price increased by HC Wainwright from $18.00 to $22.00. The firm currently has a buy rating on the stock.
EagleRock Land (NYSE:EROK) had its price target boosted by Barclays PLC from $25.00 to $27.00. They currently have an overweight rating on the stock.
Energy Transfer (NYSE:ET) had its price target raised by Truist Financial Corporation from $23.00 to $25.00. The firm currently has a buy rating on the stock.
eToro Group (NASDAQ:ETOR) had its target price lowered by Mizuho from $60.00 to $52.00. Mizuho currently has an outperform rating on the stock.
eToro Group (NASDAQ:ETOR) had its price target reduced by Needham & Company LLC from $66.00 to $53.00. They currently have a buy rating on the stock.
eToro Group (NASDAQ:ETOR) had its target price reduced by Cantor Fitzgerald from $61.00 to $53.00. Cantor Fitzgerald currently has an overweight rating on the stock.
eToro Group (NASDAQ:ETOR) had its price target trimmed by Keefe, Bruyette & Woods from $45.00 to $35.00. The firm currently has a market perform rating on the stock.
eToro Group (NASDAQ:ETOR) had its target price reduced by UBS Group AG from $50.00 to $35.00. They currently have a neutral rating on the stock.
EVE (NYSE:EVEX) had its price target boosted by JPMorgan Chase & Co. from $6.00 to $6.50. The firm currently has an overweight rating on the stock.
Evolent Health (NYSE:EVH) had its target price trimmed by Truist Financial Corporation from $7.00 to $6.00. Truist Financial Corporation currently has a hold rating on the stock.
Expand Energy (NASDAQ:EXE) had its price target lowered by Benchmark Co. from $124.00 to $109.00. The firm currently has a buy rating on the stock.
Exodus Movement (NYSEAMERICAN:EXOD) had its price target boosted by Cantor Fitzgerald from $14.00 to $15.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Adherex Technologies (NASDAQ:FENC) had its target price increased by Wedbush from $13.00 to $16.00. The firm currently has an outperform rating on the stock.
Firefly Aerospace (NASDAQ:FLY) had its price target trimmed by B. Riley Financial, Inc. from $60.00 to $50.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
First Industrial Realty Trust (NYSE:FR) had its price target raised by Scotiabank from $63.00 to $66.00. The firm currently has a sector perform rating on the stock.
Genuit Group (LON:GEN) had its price target boosted by Jefferies Financial Group Inc. from GBX 332 to GBX 366. They currently have a buy rating on the stock.
Genuit Group (LON:GEN) had its target price increased by JPMorgan Chase & Co. from GBX 440 to GBX 450. The firm currently has an overweight rating on the stock.
Glencore (LON:GLEN) had its price target boosted by Citigroup Inc. from GBX 770 to GBX 780. The firm currently has a buy rating on the stock.
Granite Point Mortgage Trust (NYSE:GPMT) had its price target reduced by Keefe, Bruyette & Woods from $1.50 to $1.25. They currently have a market perform rating on the stock.
Harvard Bioscience (NASDAQ:HBIO) had its price target boosted by Benchmark Co. from $6.00 to $7.50. They currently have a speculative buy rating on the stock.
HBT Financial (NASDAQ:HBT) had its price target boosted by Hovde Group from $40.00 to $44.00. Hovde Group currently has an outperform rating on the stock.
Hamilton Insurance Group (NYSE:HG) had its price target increased by Keefe, Bruyette & Woods from $39.00 to $40.00. The firm currently has an outperform rating on the stock.
Hikma Pharmaceuticals (LON:HIK) had its target price boosted by Citigroup Inc. from GBX 1,700 to GBX 1,870. The firm currently has a buy rating on the stock.
Helios Technologies (NYSE:HLIO) had its price target raised by JPMorgan Chase & Co. from $100.00 to $110.00. The firm currently has an overweight rating on the stock.
H&R Block (NYSE:HRB) had its target price increased by Barrington Research from $50.00 to $60.00. They currently have an outperform rating on the stock.
Iamgold (NYSE:IAG) (TSE:IMG) had its price target increased by Scotiabank from $22.00 to $23.00. They currently have a sector perform rating on the stock.
Immunome (NASDAQ:IMNM) had its target price boosted by Truist Financial Corporation from $37.00 to $38.00. They currently have a buy rating on the stock.
Informa (LON:INF) had its target price increased by Citigroup Inc. from GBX 990 to GBX 1,090. The firm currently has a buy rating on the stock.
Innate Pharma (NASDAQ:IPHA) had its target price boosted by BTIG Research from $8.00 to $9.00. They currently have a buy rating on the stock.
Janus International Group (NYSE:JBI) had its price target reduced by UBS Group AG from $6.00 to $5.60. UBS Group AG currently has a neutral rating on the stock.
JBS (NYSE:JBS) had its price target reduced by JPMorgan Chase & Co. from $18.00 to $17.50. They currently have an overweight rating on the stock.
James River Group (NASDAQ:JRVR) had its price target reduced by Truist Financial Corporation from $6.00 to $5.00. They currently have a hold rating on the stock.
Kinetik (NYSE:KNTK) had its price target raised by Truist Financial Corporation from $53.00 to $59.00. The firm currently has a buy rating on the stock.
Joint Stock Company Kaspi.kz (NASDAQ:KSPI) had its price target boosted by Susquehanna from $95.00 to $100.00. They currently have a neutral rating on the stock.
Lamar Advertising (NASDAQ:LAMR) had its target price raised by Wells Fargo & Company from $150.00 to $151.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Lithium Americas (Argentina) (NYSE:LAR) had its price target trimmed by Scotiabank from $10.00 to $9.50. They currently have a sector outperform rating on the stock.
LB Pharmaceuticals (NASDAQ:LBRX) had its price target raised by BMO Capital Markets from $46.00 to $54.00. They currently have an outperform rating on the stock.
Legend Biotech (NASDAQ:LEGN) had its target price lowered by TD Cowen from $29.00 to $24.00. They currently have a hold rating on the stock.
Legend Biotech (NASDAQ:LEGN) had its price target trimmed by Royal Bank Of Canada from $59.00 to $58.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Lumentum (NASDAQ:LITE) had its price target raised by JPMorgan Chase & Co. from $1,165.00 to $1,280.00. They currently have an overweight rating on the stock.
Lowe’s Companies (NYSE:LOW) had its target price trimmed by Royal Bank Of Canada from $232.00 to $231.00. The firm currently has a sector perform rating on the stock.
Mid-America Apartment Communities (NYSE:MAA) had its target price reduced by Morgan Stanley from $155.00 to $147.00. Morgan Stanley currently has an overweight rating on the stock.
Medline (NASDAQ:MDLN) had its target price lowered by JPMorgan Chase & Co. from $53.00 to $46.00. They currently have an overweight rating on the stock.
MidCap Financial Investment (NASDAQ:MFIC) had its price target reduced by Royal Bank Of Canada from $11.00 to $10.00. The firm currently has a sector perform rating on the stock.
Middleby (NASDAQ:MIDD) had its price target cut by JPMorgan Chase & Co. from $151.00 to $141.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Mobia Medical (NASDAQ:MOBI) had its target price increased by JPMorgan Chase & Co. from $15.00 to $17.00. They currently have an overweight rating on the stock.
Microsoft (NASDAQ:MSFT) had its price target increased by Wells Fargo & Company from $650.00 to $700.00. The firm currently has an overweight rating on the stock.
Newmont (NYSE:NEM) had its target price raised by Scotiabank from $147.00 to $149.00. Scotiabank currently has a sector outperform rating on the stock.
Neurogene (NASDAQ:NGNE) had its target price reduced by Canaccord Genuity Group Inc. from $180.00 to $166.00. They currently have a buy rating on the stock.
Neurogene (NASDAQ:NGNE) had its price target trimmed by HC Wainwright from $70.00 to $65.00. They currently have a buy rating on the stock.
Natera (NASDAQ:NTRA) had its price target raised by Piper Sandler from $249.00 to $363.50. Piper Sandler currently has an overweight rating on the stock.
Ocado Group (LON:OCDO) had its price target increased by JPMorgan Chase & Co. from GBX 245 to GBX 290. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Omada Health (NASDAQ:OMDA) had its price target boosted by Robert W. Baird from $15.00 to $25.00. They currently have a neutral rating on the stock.
Onity Group (NYSE:ONIT) had its price target cut by Keefe, Bruyette & Woods from $58.00 to $55.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
ON (NYSE:ONON) had its price target trimmed by Robert W. Baird from $70.00 to $55.00. The firm currently has an outperform rating on the stock.
ON (NYSE:ONON) had its target price lowered by Telsey Advisory Group from $51.00 to $43.00. The firm currently has an outperform rating on the stock.
ON (NYSE:ONON) had its target price lowered by UBS Group AG from $83.00 to $73.00. UBS Group AG currently has a buy rating on the stock.
Palo Alto Networks (NASDAQ:PANW) had its target price increased by Citizens Jmp from $320.00 to $415.00. The firm currently has a market outperform rating on the stock.
PENN Entertainment (NASDAQ:PENN) had its price target raised by Morgan Stanley from $19.00 to $20.00. They currently have an equal weight rating on the stock.
Persimmon (LON:PSN) had its target price reduced by Jefferies Financial Group Inc. from GBX 1,591 to GBX 1,590. The firm currently has a buy rating on the stock.
QuickLogic (NASDAQ:QUIK) had its price target lowered by Needham & Company LLC from $22.00 to $20.00. Needham & Company LLC currently has a buy rating on the stock.
Rapport Therapeutics (NASDAQ:RAPP) had its target price boosted by HC Wainwright from $40.00 to $66.00. They currently have a buy rating on the stock.
Radcom (NASDAQ:RDCM) had its target price lowered by Needham & Company LLC from $18.00 to $14.00. They currently have a buy rating on the stock.
Chicago Atlantic Real Estate Finance (NASDAQ:REFI) had its price target trimmed by Citizens Jmp from $18.00 to $16.00. They currently have a market outperform rating on the stock.
Riley Exploration Permian (NYSE:REPX) had its price target lowered by Truist Financial Corporation from $47.00 to $41.00. The firm currently has a buy rating on the stock.
Rexford Industrial Realty (NYSE:REXR) had its target price increased by Scotiabank from $36.00 to $38.00. The firm currently has a sector outperform rating on the stock.
SEA (NYSE:SE) had its target price raised by Benchmark Co. from $140.00 to $175.00. They currently have a buy rating on the stock.
Septerna (NASDAQ:SEPN) had its target price raised by Wells Fargo & Company from $48.00 to $50.00. The firm currently has an overweight rating on the stock.
Septerna (NASDAQ:SEPN) had its target price boosted by HC Wainwright from $40.00 to $60.00. HC Wainwright currently has a buy rating on the stock.
Sagimet Biosciences (NASDAQ:SGMT) had its target price boosted by Canaccord Genuity Group Inc. from $49.00 to $56.00. The firm currently has a buy rating on the stock.
Shaftesbury Capital (LON:SHC) had its target price boosted by Deutsche Bank Aktiengesellschaft from GBX 185 to GBX 195. They currently have a buy rating on the stock.
Beauty Health (NASDAQ:SKIN) had its target price cut by TD Cowen from $1.00 to $0.90. TD Cowen currently has a hold rating on the stock.
Summit Midstream Partners (NYSE:SMC) had its target price increased by TD Cowen from $39.00 to $43.00. They currently have a buy rating on the stock.
Super Micro Computer (NASDAQ:SMCI) had its target price increased by Rosenblatt Securities from $45.00 to $51.00. Rosenblatt Securities currently has a buy rating on the stock.
Super Micro Computer (NASDAQ:SMCI) had its price target raised by Wedbush from $34.00 to $40.00. The firm currently has a neutral rating on the stock.
Spirax-Sarco Engineering (LON:SPX) had its price target boosted by JPMorgan Chase & Co. from GBX 7,800 to GBX 8,600. JPMorgan Chase & Co. currently has a neutral rating on the stock.
St. James’s Place (LON:STJ) had its price target reduced by Citigroup Inc. from GBX 1,830 to GBX 1,820. Citigroup Inc. currently has a buy rating on the stock.
Stereotaxis (NYSEAMERICAN:STXS) had its price target lowered by TD Cowen from $5.00 to $3.00. The firm currently has a buy rating on the stock.
T1 Energy (NYSE:TE) had its target price increased by BTIG Research from $8.00 to $9.00. BTIG Research currently has a buy rating on the stock.
Telecom Argentina Stet – France Telecom (NYSE:TEO) had its price target cut by UBS Group AG from $18.00 to $16.50. They currently have a buy rating on the stock.
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by Barclays PLC from $40.00 to $42.00. They currently have an overweight rating on the stock.
Tencent Music Entertainment Group (NYSE:TME) had its price target lowered by Mizuho from $18.00 to $15.00. Mizuho currently has an outperform rating on the stock.
Terreno Realty (NYSE:TRNO) had its target price increased by Scotiabank from $68.00 to $72.00. Scotiabank currently has a sector outperform rating on the stock.
ServiceTitan (NASDAQ:TTAN) had its target price raised by Robert W. Baird from $94.00 to $101.00. Robert W. Baird currently has an outperform rating on the stock.
Taylor Wimpey (LON:TW) had its target price reduced by Jefferies Financial Group Inc. from GBX 102 to GBX 101. Jefferies Financial Group Inc. currently has a buy rating on the stock.
TWFG (NASDAQ:TWFG) had its price target boosted by Keefe, Bruyette & Woods from $26.00 to $29.00. The firm currently has a market perform rating on the stock.
United States Antimony (NYSE:UAMY) had its price target cut by HC Wainwright from $11.75 to $9.25. HC Wainwright currently has a buy rating on the stock.
Unilever (LON:ULVR) had its target price raised by Jefferies Financial Group Inc. from GBX 3,800 to GBX 3,900. Jefferies Financial Group Inc. currently has an underperform rating on the stock.
Vera Therapeutics (NASDAQ:VERA) had its price target trimmed by HC Wainwright from $125.00 to $90.00. They currently have a buy rating on the stock.
Venture Global (NYSE:VG) had its price target increased by Wells Fargo & Company from $14.00 to $15.00. They currently have an equal weight rating on the stock.
Vor Biopharma (NASDAQ:VOR) had its price target increased by Wedbush from $18.00 to $27.00. They currently have a neutral rating on the stock.
Vestis (NYSE:VSTS) had its target price increased by Robert W. Baird from $15.00 to $16.00. The firm currently has a neutral rating on the stock.
WBI (NYSE:WBI) had its price target increased by Morgan Stanley from $38.00 to $43.00. Morgan Stanley currently has an overweight rating on the stock.
Williams Companies (NYSE:WMB) had its target price raised by Truist Financial Corporation from $84.00 to $88.00. The firm currently has a buy rating on the stock.
Receive News & Ratings for Agilent Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.
